Enhancing Postoperative Decision‐Making in Esophageal Cancer: Clinical Perspectives and Future Research Needs
Huazhen Wu, Jia Liao, Lishan Hu, Siwen Li · 2026
Read Enhancing Postoperative Decision‐Making in Esophageal Cancer: Clinical Perspectives and Future Research Needs by Huazhen Wu, Jia Liao, Lishan Hu, Siwen Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13158369.txt.
Description
Huazhen Wu and co-authors write this 2026 letter on care choices after surgery for esophageal cancer. They praise a study that used tumor regression grade to guide extra therapy after pre-surgery treatment. Patients whose tumors shrank well, and some with deeper disease, gained survival from added therapy. The grade could sharpen guidelines, they agree.
Still, they raise three worries. The study lumped distinct drug plans into one group, which can blur true effects. Its backward-looking design risks bias, since fitter patients get more therapy. Grade scoring is also partly a matter of judgment, with no central review. They urge split results by regimen, stronger causal methods, digital scoring, and pairing the grade with blood markers.
Catalog record
| CREATOR | Huazhen Wu, Jia Liao, Lishan Hu, Siwen Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |